Strategy & Corporate Planning

Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering – Amsterdam, 30 Nov – 4 Dec 2026

Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering runs in Amsterdam from Monday 30 November to Friday 4 December 2026 (1 Week). The fee is 23,500 SAR per participant. The same programme is also scheduled in 7 other cities.

Register for this programme Ask a question

Dates
Length
1 Week
Fee per participant
23,500 SAR
Format
In person, Amsterdam
Venue
Zuidas business district hotel
Status
Open for registration
Week
49 of 2026
Reference
576_17585

This session

30 Nov – 4 Dec 2026

This Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering session in Amsterdam runs from Monday 30 November to Friday 4 December 2026 (week 49, Q4 2026). It is the only date in Amsterdam in 2026, at a fee of 23,500 SAR. Registration is open for this date. It is held in person at Zuidas business district hotel.

How do I book this date?

Register online to request your place, or send us a question about this date first.

Reference for this date: 576_17585. Quote it when you contact us.

Before you book, read our cancellation policy.

Let’s talk about your next step.

Questions about this date

When does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering in Amsterdam start and finish?

It starts on Monday 30 November and finishes on Friday 4 December 2026: 1 Week.

How much does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering in Amsterdam cost?

The fee for this date is 23,500 SAR per participant. Please read our cancellation policy before you book.

Is this date held in person or online?

It is held in person in Amsterdam, at Zuidas business district hotel.

Where else does Biotechnology Business Fundamentals: Biopharma Pipeline, Licensing and Partnering run?

It is also scheduled in 7 other cities: Barcelona, Dammam, Dubai, Jeddah, London, Paris and Riyadh.

What does this programme cover?

Biotechnology business decisions are increasingly made by managers, investors and officials who never trained as scientists. Without a working grasp of how biologic medicines are discovered, developed, protected, financed and made, they misread pipeline risk, overpay for early assets, sign licences with the wrong milestones or back manufacturing plans that never fill. This Core Concept course gives non-scientist professionals the science vocabulary, pipeline economics, deal structures and ecosystem logic of the biopharma sector. Participants finish with a Biotech Asset Evaluation and Partnering Strategy for a case asset.

The programme outline covers:

  • Introduction
  • Course Objectives
  • Target Audience
  • Course Outline
  • Day 1: Biotechnology Science Essentials for Non-Scientists
  • Day 2: Therapeutic Modalities and the Development Pipeline
  • Day 3: Regulation, Intellectual Property and Asset Valuation
  • Day 4: Funding, Partnering, Manufacturing and Market Access
  • Day 5: Biotech Ecosystem Strategy and Partnering Case
  • Skills You Will Gain
  • Why Attend This Course
  • Conclusion
Read the full outline on the programme page ↗

Where else does this programme run?

Also scheduled in 7 other cities.

More ways to train